Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000693304 | SCV000821166 | uncertain significance | Hereditary spastic paraplegia 75 | 2019-04-30 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals with MAG-related disease. This variant is present in population databases (rs147583558, ExAC 0.02%). This sequence change replaces arginine with histidine at codon 465 of the MAG protein (p.Arg465His). The arginine residue is highly conserved and there is a small physicochemical difference between arginine and histidine. |
Ambry Genetics | RCV003343999 | SCV004065934 | uncertain significance | Inborn genetic diseases | 2023-06-21 | criteria provided, single submitter | clinical testing | The c.1394G>A (p.R465H) alteration is located in exon 8 (coding exon 6) of the MAG gene. This alteration results from a G to A substitution at nucleotide position 1394, causing the arginine (R) at amino acid position 465 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |